在慢性淋巴细胞白血病中实现精准医学:剩余的挑战和潜在的机会
Kostas Stamatopoulos1,2, Sarka Pavlova3,4, Othman Al-Sawaf5,6,7
1Centre for Research and Technology Hellas Institute of Applied Biosciences Thessaloniki Greece.
HemaSphere
|July 22, 2024
概括
慢性淋巴细胞白血病 (CLL) 的精准医学涉及先进的基因测试和向治疗. 个性化治疗考虑了患者的旅程,生活方式和最佳结果的偏好.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 慢性淋巴细胞白血病 (CLL) 的临床结果各不相同.
- 基因检测,包括del(17p),TP53突变和IGHV状态,有助于风险分层.
- 针对性疗法,如酶和BCL2抑制剂,正在推动CLL治疗.
研究的目的:
- 审查当前和新兴的诊断测试,以识别高风险的CLL患者.
- 讨论平衡安全性,疗效和患者特定因素的治疗范式.
- 探索治疗耐药性机制和可测量的残留疾病监测的作用.
主要方法:
- 对诊断测试的审查 (细胞遗传学,测序).
- 针对性治疗 (激酶和BCL2抑制剂) 的分析.
- 讨论治疗选择,耐药性和监测策略.
主要成果:
- 基因标记物可以识别高风险的CLL患者进行向治疗.
- 个性化医学超越了遗传学,包括患者的旅程和偏好.
- 可测量的残留疾病监测对于指导治疗决策至关重要.
结论:
- 在CLL中,精准医学需要整合诊断,向治疗和以患者为中心的护理.
- 包括生活方式和并发症在内的整体患者评估对于真正的个性化医学至关重要.
- 现实世界的数据聚合和全球视角增强了CLL管理策略.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.3K
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
9.9K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K